Alaunos Therapeutics (TCRT) Earnings Analysis

Alaunos Therapeutics (TCRT) next reports earnings on 2026-08-18. It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E -0.90.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does TCRT next report earnings?

Next earnings date2026-08-18
Consensus EPS estimaten/a
Revenue estimaten/a

TCRT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-0.59 USDn/an/an/a
2026-03-31-0.4 USD-3.68575 USD+89.1%Beat
2025-11-14-0.55 USD-4.9039 USD+88.8%Beat
2025-08-14-0.63 USD-5.33399 USD+88.2%Beat
2025-05-15-0.67 USD-6.43983 USD+89.6%Beat
2025-03-31-0.46 USD-4.5 USD+89.8%Beat
2024-11-14-0.7 USD-4.5 USD+84.4%Beat
2024-08-14-0.71 USD-4.5 USD+84.2%Beat

Beat rate: 7/7 (100%) over reported quarters with consensus data.

TCRT valuation and analyst view

Trailing P/E-0.90
Trailing EPS-2.10896 USD
Price / book2.95
Dividend yield0.00%
Market cap0.00B
Analyst consensusHold (1 buy / 8 hold / 1 sell)

Related research pages

Frequently asked questions

When is Alaunos Therapeutics (TCRT)'s next earnings date?

Alaunos Therapeutics is next scheduled to report on 2026-08-18.

Did TCRT beat earnings last quarter?

Consensus estimate data was not available for TCRT's 2026-05-15 report.

What is TCRT's earnings track record?

Over the last 7 reported quarters with consensus data, TCRT beat estimates 7 times (100%).

What is TCRT's current P/E ratio and EPS?

TCRT trades at a trailing P/E of -0.90 on trailing EPS of -2.1089564181512936 USD.

What do analysts rate TCRT?

Analyst consensus is "Hold" across 10 ratings (0 strong buy, 1 buy, 8 hold, 1 sell, 0 strong sell).